
Schneeberger
Facing ongoing competitive pressures and market growth demands, life science and biomedical original equipment manufacturers (OEMs) must constantly deliver new advancements in technology, processes, workflows, and production. But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.
In the case of advanced instruments used in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component – in-process linear motion systems – can generate consequences ranging from inconvenient to catastrophic.
This white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing – and ensure against failures of any consequence.
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Latest from Today's Medical Developments
- US manufacturing technology orders grow in March 2025
- Norman Noble boosts nitinol inventory for faster prototyping
- From honeybee brains and Egyptian mummies to customized human implants
- Star SU partners with REGO-FIX for cutting-edge machining solutions
- Maximize Efficiency with the WPG 7's Innovative Design
- Cybord and Siemens join forces to revolutionize manufacturing quality
- Nikon's VOXLS 20 C 225: The future of X-ray inspection
- Inside the making of smart soft robots for medical use